(Q37756342)

22 August 2017

1 reference

title

Current concepts and future directions in the diagnosis and management of lymphatic vascular disease (English)

1 reference

22 August 2017

0 references

Stanley G Rockson

1

1 reference

22 August 2017

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

15

1 reference

22 August 2017

3

1 reference

22 August 2017

223-231

1 reference

Lymphatic vasculature development

22 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Diagnosis and management of lymphatic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Evidence for a second valve system in lymphatics: endothelial microvalves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

A model for mechanics of primary lymphatic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Molecular regulation of lymphatic contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Contractile physiology of lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

The unique biology of lymphatic edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Immune traffic: a functional overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Cell traffic and the lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Macrophage and tissue changes in the developmental phases of secondary lymphoedema and during conservative therapy with benzopyrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

The interstitium, the connective tissue environment of the lymphatic, and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Inflammatory manifestations of experimental lymphatic insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Liposuction in arm lymphedema treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Biomarkers of lymphatic function and disease: state of the art and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

A stepwise model of the development of lymphatic vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

New insights into the molecular control of the lymphatic vascular system and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Molecular and biological properties of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Lymphatic vasculature development: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Candidate gene analysis in primary lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Imaging of the lymphatic system: new horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Quality of life of breast cancer patients with lymphedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Disrupted social connectedness among Dominican women with chronic filarial lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

The psycho-social impact of lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Psychologic and social sequelae of secondary lymphedema: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

The role of the lymphatic circulation in the natural history and expression of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Home-based lymphedema treatment in patients with cancer-related lymphedema or noncancer-related lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

A model for gene therapy of human hereditary lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Molecular control of lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

High-Resolution MR Lymphangiography in Patients with Primary and Secondary Lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

Mr Imaging of Primary, Secondary, and Mixed Forms of Lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X10364553

21 January 2018

Identifiers

DOI

10.1177/1358863X10364553

1 reference

22 August 2017

1 reference

PubMed ID

20483987